These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 22940378)

  • 1. The impact of new vaccine introduction on immunization and health systems: a review of the published literature.
    Hyde TB; Dentz H; Wang SA; Burchett HE; Mounier-Jack S; Mantel CF;
    Vaccine; 2012 Oct; 30(45):6347-58. PubMed ID: 22940378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs of vaccine programs across 94 low- and middle-income countries.
    Portnoy A; Ozawa S; Grewal S; Norman BA; Rajgopal J; Gorham KM; Haidari LA; Brown ST; Lee BY
    Vaccine; 2015 May; 33 Suppl 1():A99-108. PubMed ID: 25919184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Status of New Vaccine Introduction - Worldwide, September 2016.
    Loharikar A; Dumolard L; Chu S; Hyde T; Goodman T; Mantel C
    MMWR Morb Mortal Wkly Rep; 2016 Oct; 65(41):1136-1140. PubMed ID: 27764083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Policy analysis of the use of hepatitis B, Haemophilus influenzae type b-, Streptococcus pneumoniae-conjugate and rotavirus vaccines in national immunization schedules.
    Miller MA; McCann L
    Health Econ; 2000 Jan; 9(1):19-35. PubMed ID: 10694757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence-based decision-making for vaccine introductions: Overview of the ProVac International Working Group's experience.
    Jauregui B; Garcia AG; Bess Janusz C; Blau J; Munier A; Atherly D; Mvundura M; Hajjeh R; Lopman B; Clark AD; Baxter L; Hutubessy R; de Quadros C; Andrus JK
    Vaccine; 2015 May; 33 Suppl 1(0 1):A28-33. PubMed ID: 25919170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Budget impact analysis of vaccination against Haemophilus influenzae type b as a part of a Pentavalent vaccine in the childhood immunization schedule of Iran.
    Teimouri F; Kebriaeezadeh A; Zahraei SM; Gheiratian M; Nikfar S
    Daru; 2017 Jan; 25(1):1. PubMed ID: 28088246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New vaccine introductions: assessing the impact and the opportunities for immunization and health systems strengthening.
    Wang SA; Hyde TB; Mounier-Jack S; Brenzel L; Favin M; Gordon WS; Shearer JC; Mantel CF; Arora N; Durrheim D
    Vaccine; 2013 Apr; 31 Suppl 2(0 2):B122-8. PubMed ID: 23598473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.
    Peny JM; Gleizes O; Covilard JP
    Vaccine; 2005 Aug; 23(37):4610-8. PubMed ID: 15979769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of introducing new vaccines on the health system: case studies from six low- and middle-income countries.
    Burchett HE; Mounier-Jack S; Torres-Rueda S; Griffiths UK; Ongolo-Zogo P; Rulisa S; Edengue JM; Chavez E; Kitaw Y; Molla M; Konate M; Gelmon L; Onyango-Ouma W; Lagarde M; Mills A
    Vaccine; 2014 Nov; 32(48):6505-12. PubMed ID: 25261379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of new vaccine introduction on the coverage of existing vaccines: a cross-national, multivariable analysis.
    Shearer JC; Walker DG; Risko N; Levine OS
    Vaccine; 2012 Dec; 30(52):7582-7. PubMed ID: 23099327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What have we learned on costs and financing of routine immunization from the comprehensive multi-year plans in GAVI eligible countries?
    Brenzel L
    Vaccine; 2015 May; 33 Suppl 1():A93-8. PubMed ID: 25919183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustainable introduction of affordable new vaccines: the targeting strategy.
    Batson A
    Vaccine; 1998 Nov; 16 Suppl():S93-8. PubMed ID: 9915047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination in Southeast Asia--reducing meningitis, sepsis and pneumonia with new and existing vaccines.
    Richardson A; Morris DE; Clarke SC
    Vaccine; 2014 Jul; 32(33):4119-23. PubMed ID: 24907487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examining the cost of delivering routine immunization in Honduras.
    Janusz CB; Castañeda-Orjuela C; Molina Aguilera IB; Felix Garcia AG; Mendoza L; Díaz IY; Resch SC
    Vaccine; 2015 May; 33 Suppl 1():A53-9. PubMed ID: 25919175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The new National Immunization Program 2017-2019 and the Essential Care Levels: what is going to change?].
    De Waure C; Sisti LG; Poscia A; Ricciardi W
    Ig Sanita Pubbl; 2017; 73(5):405-418. PubMed ID: 29433128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
    Menzies R; Turnour C; Chiu C; McIntyre P
    Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ProVac Global Initiative: a vision shaped by ten years of supporting evidence-based policy decisions.
    Jauregui B; Janusz CB; Clark AD; Sinha A; Garcia AG; Resch S; Toscano CM; Sanderson C; Andrus JK
    Vaccine; 2015 May; 33 Suppl 1():A21-7. PubMed ID: 25919164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The composition of demand for newly launched vaccines: results from the pneumococcal and rotavirus vaccine introductions in Ethiopia and Malawi.
    Williams BA; Kidane T; Chirwa G; Tesfaye N; Prescott MR; Scotney ST; Valle M; Abebe S; Tambuli A; Malewezi B; Mohammed T; Kobayashi E; Wootton E; Wong R; Dosani R; Subramaniam H; Joseph J; Yavuz E; Apple A; Le Tallec Y; Kang'ethe A
    Health Policy Plan; 2016 Jun; 31(5):563-72. PubMed ID: 26856361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review of incremental non-vaccine cost estimates used in cost-effectiveness analysis on the introduction of rotavirus and pneumococcal vaccines.
    De la Hoz-Restrepo F; Castañeda-Orjuela C; Paternina A; Alvis-Guzman N
    Vaccine; 2013 Jul; 31 Suppl 3():C80-7. PubMed ID: 23777697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
    Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
    Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.